A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using… | Written by Good News Network | Good News Network | Read full story at Read More
Discover more from Endless Glory Media
Subscribe to get the latest posts sent to your email.


